Role of anti-HBs in functional cure of HBeAg chronic hepatitis B patients infected with HBV genotype A.

Hui Xu; Stephen Locarnini; Darren Wong; Rachel Hammond; Danni Colledge; Sally Soppe; Thao Huynh; Tim Shaw; Alexander J Thompson; Peter A Revill; P Mark Hogarth; Bruce D Wines; Renae Walsh; Nadia Warner

Journal article

Role of anti-HBs in functional cure of HBeAg chronic hepatitis B patients infected with HBV genotype A.

Hui Xu, Stephen Locarnini, Darren Wong, Rachel Hammond, Danni Colledge, Sally Soppe, Thao Huynh, Tim Shaw, Alexander J Thompson, Peter A Revill, P Mark Hogarth, Bruce D Wines, Renae Walsh, Nadia Warner

J Hepatol | Elsevier BV | Published : 2021

DOI: 10.1016/j.jhep.2021.07.031

Abstract

BACKGROUND & AIMS: HBsAg-specific antibody responses are difficult to detect during chronic hepatitis B infection (CHB) and are often overlooked. The aim of this study was to examine whether anti-HBs may be involved in functional cure (FC) by profiling anti-HBs responses in patients with CHB using a panel of specific assays. METHODS: Longitudinal serum samples were obtained from 25 patients with CHB who were infected with HBV genotype A and were undergoing nucleos(t)ide analogue (NA) treatment: 14 achieved FC while 11 remained infected (non-FC). Anti-HBs immune complexes (HBsAg-IC), FcγRIIIa dimer binding, epitope specificity and neutralisation efficacy were measured. RESULTS: HBsAg-IC peaks..

View full abstract